Archive for year: 2022

Commercialization of our second SARS-CoV-2 detection test by RT-qPCR

Laboratoire OBO, France – 21 March 2022 A new CE-IVD marked test, the OSANTYS SARS-CoV-2 Duo RT-qPCR kit, allows for rapid (without extraction) and standardised detection of Sars-Cov-2 from a simple cell lysate, regardless of the type of…

New HPV test soon on the market

Laboratoire OBO, France – 04 February 2022 The ongoing development of a high-risk human papillomavirus (HPV) detection test using real-time PCR with partial genotyping. This kit will allow for the individualised identification of 3 genotypes…